@dansfera: Timing the market around FDA approvals is high-stakes chess, not checkers. For those watching the charts, July 29th marks the critical ADCOM catalyst, but the real play might be waiting for the dust to settle before betting on that August 22nd FDA date. It’s a classic risk-versus-reward dilemma: get in early for the potential pop or play it safe and watch the process unfold. Whether this play makes the cut for a full deep dive depends on the momentum leading up to the final decision. #investing #stockmarket #tradingtips #fdacatalyst #finance